Exact Sciences (EXAS) Current Deferred Revenue (2010 - 2013)

Exact Sciences (EXAS) has 4 years of Current Deferred Revenue data on file, last reported at $294000.0 in Q4 2013.

• Current Deferred Revenue for Q4 2013 came in at $294000.0, down 92.9% year-over-year; the trailing twelve-month figure through Dec 2013 was $294000.0 (down 92.9% YoY), and the FY2013 annual result was $294000.0, down 92.9% from the prior year.
• Current Deferred Revenue slipped to $294000.0 in Q4 2013 per EXAS's latest filing, from $1.3 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $4.1 million in Q4 2010 and troughed at $294000.0 in Q4 2013.
• A 4-year average of $3.4 million and a median of $4.1 million in 2010 frame the typical range for Current Deferred Revenue.
• The sharpest annual moves came in 2011 and 2013: Current Deferred Revenue changed 0.0% in 2011, then slumped 92.9% in 2013.
• A 4-year view of Current Deferred Revenue shows it stood at $4.1 million in 2010, then changed by 0.0% to $4.1 million in 2011, then changed by 0.0% to $4.1 million in 2012, then tumbled by 92.9% to $294000.0 in 2013.
• Business Quant data shows EXAS's Current Deferred Revenue at $294000.0 in Q4 2013, $1.3 million in Q3 2013, and $2.4 million in Q2 2013.